Every Tuesday we send out the MedComms Networking email newsletter to subscribers. It includes brief commentary on what we're doing and planning, and highlights relevant news to encourage sharing of information, experiences and ideas and to stimulate discussion. The text and links included below, by definition, were accurate on the day of publication, but may then become outdated.
MedComms Networking - 29 October 2019
Ah, kids. Just love 'em... School holidays are such fun. If you don't need to work as well. Luckily, to speed things up today I can simply list all the new videos from last week. When I could work some full days.
We started by marking Open Access Week 2019, hearing about results from several recent, published research projects around the topic of open access publication of pharmaceutical industry research and the role of professional medical writers. It's clear the industry does better than is often acknowledged, that policies from many journals make it stupidly tough for industry to genuinely publish fully open access, and that professional writers do speed up publication and improve quality of articles.
By the way, this appeared from the Alltrials campaign last week; UK universities and NHS trusts that flout the rules on clinical trials identified in report to Parliament.
Remember, we're not doing so bad after all.
I hope you'll get behind the Open Pharma position statement on open access, presented by Chris Winchester of Oxford PharmaGenesis. As an aside, the initiative was covered by the Telegraph newspaper, in Drug companies urged to make research available to health workers in poorer countries. It's not often MedComms hits the national press so directly. Kudos to all involved.
So, gather your colleagues, share some cake, watch these and discuss...
Disclosing the results of clinical trials: how is the pharmaceutical industry doing? presented by Gemma Rogers of Oxford PharmaGenesis
Good Practice for Conference Abstracts and Presentations: GPCAP presented by Jackie Marchington of Caudex
Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review presented by Obaro Evuarherhe of Oxford PharmaGenesis
Open access policies of leading medical journals: a cross-sectional study, presented by Tim Ellison of Oxford PharmaGenesis
On Wednesday, we recorded an excellent online session with Emma Georgiou, Jane Mason and Sarah Smith, talking about life as a MedComms freelancer. We skipped over lots of topics very quickly, but hopefully provided useful insights into what to consider if you're making the move.
Then, on Friday, John Dixon added three more Writing Bites to our growing collection...
Can you start a sentence with ‘but’ or ‘and’?
Proved or proven?
Be careful using ‘because’ after a negative statement
Now this week, assuming I survive an over-dose of child care duties, we'll talk in tomorrow's Webinar about properly using LinkedIn. How to connect with (almost) anyone in the MedComms world will be led by Steve Doyle. Everyone's welcome.
Next week we'll talk about Best Practice in Medical Education. Leigh van Wyk, Tracey Wood and Phil Loder of Ogilvy Health will look at latest thinking and best practice in medical education, covering topics such as pharma standards, needs assessments, principles of adult learning, and measurement of outcomes. Please encourage all relevant others to join us.
Remember, details of all our activities are kept bang up-to-date at www.MedCommsNetworking.com or give me a shout at any time if you've any questions, comments or suggestions.
Managing Director, NetworkPharma Ltd
Follow me on Twitter @NetworkPharma
Join 4,000 international colleagues in the MedComms Networking Linkedin Group
The information at www.MedCommsNetworking.com is always bang up-to-date!